Search research articles
Contact Us
Filters
Showing results (931-940 of 1,104) with videos related to
Page
of 111
Sort By:
European Journal of Haematology
|
June 15, 2023
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial
Alexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.
International Journal of Hematology
|
June 5, 2010
Clinical course of non-severe aplastic anemia in adults
Ji Hyun Kwon, Inho Kim, Yun Gyoo Lee, et al.
Journal of Korean Medical Science
|
April 26, 2008
Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report
Kyu-Hyoung Lim, Sunyoung Kim, Yoon-Su Lee, et al.
British Journal of Clinical Pharmacology
|
January 21, 2025
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria
Valérie Cosson, Rong Fu, Austin Kulasekararaj, et al.
Molecules and Cells
|
November 1, 2005
Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I
Byung-Hwan Lee, Sang-Min Jeong, Sang-Min Jung, et al.
Annals of Hematology
|
January 28, 2009
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
Keun-Wook Lee, Jongyoun Yi, In Sil Choi, et al.
British Journal of Haematology
|
April 6, 2021
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial
Torben Plesner, Meletios A Dimopoulos, Albert Oriol, et al.
Blood Research
|
October 11, 2016
Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
Seok Jin Kim, Soo-Mee Bang, Yoon Seok Choi, et al.
British Journal of Haematology
|
October 10, 2024
Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome
Dong Hyun Kim, Seokhyeon Kim, Seonyang Park, et al.
Blood Research
|
July 5, 2013
Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry
Hyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, et al.
Page
of 111
Search research articles
Search
Showing results (931-940 of 1,104) with videos related to
Sort By:
Page
of 111
European Journal of Haematology
|
June 15, 2023
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial
Alexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.
International Journal of Hematology
|
June 5, 2010
Clinical course of non-severe aplastic anemia in adults
Ji Hyun Kwon, Inho Kim, Yun Gyoo Lee, et al.
Journal of Korean Medical Science
|
April 26, 2008
Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report
Kyu-Hyoung Lim, Sunyoung Kim, Yoon-Su Lee, et al.
British Journal of Clinical Pharmacology
|
January 21, 2025
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria
Valérie Cosson, Rong Fu, Austin Kulasekararaj, et al.
Molecules and Cells
|
November 1, 2005
Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I
Byung-Hwan Lee, Sang-Min Jeong, Sang-Min Jung, et al.
Annals of Hematology
|
January 28, 2009
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
Keun-Wook Lee, Jongyoun Yi, In Sil Choi, et al.
British Journal of Haematology
|
April 6, 2021
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial
Torben Plesner, Meletios A Dimopoulos, Albert Oriol, et al.
Blood Research
|
October 11, 2016
Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
Seok Jin Kim, Soo-Mee Bang, Yoon Seok Choi, et al.
British Journal of Haematology
|
October 10, 2024
Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome
Dong Hyun Kim, Seokhyeon Kim, Seonyang Park, et al.
Blood Research
|
July 5, 2013
Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry
Hyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, et al.
Page
of 111